SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2fpq'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1D4F_C_ADNC603_2 (S-ADENOSYLHOMOCYSTEI NE HYDROLASE)	2fpq	BOTULINUM NEUROTOXIN D LIGHT CHAIN (Clostridium botulinum)	4 / 5	GLU A 268 THR A 272 HIS A 229 LEU A 192	None ZN A 500 ( 4.8A) ZN A 500 (-3.1A) None	1.11A	1d4fC-2fpqA: undetectable	1d4fC-2fpqA: 22.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NKI_A_PPFA5001_1 (PROBABLE FOSFOMYCIN RESISTANCE PROTEIN)	2fpq	BOTULINUM NEUROTOXIN D LIGHT CHAIN (Clostridium botulinum)	5 / 9	TYR A 168 HIS A 229 TYR A 375 GLU A 269 HIS A 233	None ZN A 500 (-3.1A) None ZN A 500 (-1.8A) ZN A 500 (-3.3A)	1.42A	1nkiA-2fpqA: undetectable 1nkiB-2fpqA: undetectable	1nkiA-2fpqA: 15.62 1nkiB-2fpqA: 15.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NKI_B_PPFB5002_1 (PROBABLE FOSFOMYCIN RESISTANCE PROTEIN)	2fpq	BOTULINUM NEUROTOXIN D LIGHT CHAIN (Clostridium botulinum)	5 / 9	HIS A 233 TYR A 168 HIS A 229 TYR A 375 GLU A 269	ZN A 500 (-3.3A) None ZN A 500 (-3.1A) None ZN A 500 (-1.8A)	1.41A	1nkiA-2fpqA: undetectable 1nkiB-2fpqA: undetectable	1nkiA-2fpqA: 15.62 1nkiB-2fpqA: 15.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NX9_A_AICA5001_1 (ALPHA-AMINO ACID ESTER HYDROLASE)	2fpq	BOTULINUM NEUROTOXIN D LIGHT CHAIN (Clostridium botulinum)	4 / 8	TYR A 363 TYR A 367 GLU A 360 HIS A 236	None	1.29A	1nx9A-2fpqA: undetectable	1nx9A-2fpqA: 19.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NX9_B_AICB5002_1 (ALPHA-AMINO ACID ESTER HYDROLASE)	2fpq	BOTULINUM NEUROTOXIN D LIGHT CHAIN (Clostridium botulinum)	4 / 8	TYR A 363 TYR A 367 GLU A 360 HIS A 236	None	1.33A	1nx9B-2fpqA: undetectable	1nx9B-2fpqA: 19.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NX9_C_AICC5003_1 (ALPHA-AMINO ACID ESTER HYDROLASE)	2fpq	BOTULINUM NEUROTOXIN D LIGHT CHAIN (Clostridium botulinum)	4 / 8	TYR A 363 TYR A 367 GLU A 360 HIS A 236	None	1.31A	1nx9C-2fpqA: undetectable	1nx9C-2fpqA: 19.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NX9_D_AICD5004_1 (ALPHA-AMINO ACID ESTER HYDROLASE)	2fpq	BOTULINUM NEUROTOXIN D LIGHT CHAIN (Clostridium botulinum)	4 / 8	TYR A 363 TYR A 367 GLU A 360 HIS A 236	None	1.31A	1nx9D-2fpqA: undetectable	1nx9D-2fpqA: 19.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1SDT_B_MK1B902_1 (PROTEASE RETROPEPSIN)	2fpq	BOTULINUM NEUROTOXIN D LIGHT CHAIN (Clostridium botulinum)	5 / 10	LEU A 192 ILE A 91 ILE A 97 VAL A 156 ILE A 158	None	0.94A	1sdtA-2fpqA: undetectable	1sdtA-2fpqA: 15.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1V7Z_A_CRNA401_1 (CREATININE AMIDOHYDROLASE)	2fpq	BOTULINUM NEUROTOXIN D LIGHT CHAIN (Clostridium botulinum)	4 / 8	GLU A 269 HIS A 229 HIS A 233 GLU A 230	ZN A 500 (-1.8A) ZN A 500 (-3.1A) ZN A 500 (-3.3A) ZN A 500 ( 4.2A)	0.91A	1v7zA-2fpqA: undetectable	1v7zA-2fpqA: 19.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1V7Z_B_CRNB3401_1 (CREATININE AMIDOHYDROLASE)	2fpq	BOTULINUM NEUROTOXIN D LIGHT CHAIN (Clostridium botulinum)	4 / 8	GLU A 269 HIS A 229 HIS A 233 GLU A 230	ZN A 500 (-1.8A) ZN A 500 (-3.1A) ZN A 500 (-3.3A) ZN A 500 ( 4.2A)	0.90A	1v7zB-2fpqA: undetectable	1v7zB-2fpqA: 19.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1V7Z_C_CRNC4401_1 (CREATININE AMIDOHYDROLASE)	2fpq	BOTULINUM NEUROTOXIN D LIGHT CHAIN (Clostridium botulinum)	4 / 8	GLU A 269 HIS A 229 HIS A 233 GLU A 230	ZN A 500 (-1.8A) ZN A 500 (-3.1A) ZN A 500 (-3.3A) ZN A 500 ( 4.2A)	0.91A	1v7zC-2fpqA: undetectable	1v7zC-2fpqA: 19.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1V7Z_D_CRND5401_1 (CREATININE AMIDOHYDROLASE)	2fpq	BOTULINUM NEUROTOXIN D LIGHT CHAIN (Clostridium botulinum)	4 / 8	GLU A 269 HIS A 229 HIS A 233 GLU A 230	ZN A 500 (-1.8A) ZN A 500 (-3.1A) ZN A 500 (-3.3A) ZN A 500 ( 4.2A)	0.93A	1v7zD-2fpqA: undetectable	1v7zD-2fpqA: 19.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1V7Z_E_CRNE6401_1 (CREATININE AMIDOHYDROLASE)	2fpq	BOTULINUM NEUROTOXIN D LIGHT CHAIN (Clostridium botulinum)	4 / 8	GLU A 269 HIS A 229 HIS A 233 GLU A 230	ZN A 500 (-1.8A) ZN A 500 (-3.1A) ZN A 500 (-3.3A) ZN A 500 ( 4.2A)	0.92A	1v7zE-2fpqA: undetectable	1v7zE-2fpqA: 19.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1V7Z_F_CRNF7401_1 (CREATININE AMIDOHYDROLASE)	2fpq	BOTULINUM NEUROTOXIN D LIGHT CHAIN (Clostridium botulinum)	4 / 8	GLU A 269 HIS A 229 HIS A 233 GLU A 230	ZN A 500 (-1.8A) ZN A 500 (-3.1A) ZN A 500 (-3.3A) ZN A 500 ( 4.2A)	0.92A	1v7zF-2fpqA: undetectable	1v7zF-2fpqA: 19.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1WU8_C_ADNC502_1 (HYPOTHETICAL PROTEIN PH0463)	2fpq	BOTULINUM NEUROTOXIN D LIGHT CHAIN (Clostridium botulinum)	4 / 7	PHE A 399 ASN A 400 ASN A 371 VAL A 224	None	1.17A	1wu8A-2fpqA: undetectable 1wu8C-2fpqA: undetectable	1wu8A-2fpqA: 22.43 1wu8C-2fpqA: 22.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2O4P_A_TPVA300_2 (PROTEASE)	2fpq	BOTULINUM NEUROTOXIN D LIGHT CHAIN (Clostridium botulinum)	5 / 9	LEU A 192 VAL A 45 ILE A 97 VAL A 156 ILE A 158	None	0.77A	2o4pB-2fpqA: undetectable	2o4pB-2fpqA: 15.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PRG_A_BRLA1_2 (PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA)	2fpq	BOTULINUM NEUROTOXIN D LIGHT CHAIN (Clostridium botulinum)	3 / 3	ILE A 191 ILE A 136 LEU A 227	None	0.54A	2prgA-2fpqA: undetectable	2prgA-2fpqA: 20.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2R5P_B_MK1B902_1 (PROTEASE)	2fpq	BOTULINUM NEUROTOXIN D LIGHT CHAIN (Clostridium botulinum)	5 / 12	LEU A 192 VAL A 45 ILE A 97 VAL A 156 ILE A 158	None	0.91A	2r5pA-2fpqA: undetectable	2r5pA-2fpqA: 14.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2R5P_D_MK1D902_1 (PROTEASE)	2fpq	BOTULINUM NEUROTOXIN D LIGHT CHAIN (Clostridium botulinum)	5 / 12	LEU A 192 VAL A 45 ILE A 97 VAL A 156 ILE A 158	None	0.91A	2r5pC-2fpqA: undetectable	2r5pC-2fpqA: 14.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VCT_C_ASDC1223_1 (GLUTATHIONE S-TRANSFERASE A2)	2fpq	BOTULINUM NEUROTOXIN D LIGHT CHAIN (Clostridium botulinum)	4 / 8	TYR A 367 ILE A 102 GLY A 103 LEU A 110	None	0.92A	2vctC-2fpqA: undetectable	2vctC-2fpqA: 17.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VCT_D_ASDD1223_1 (GLUTATHIONE S-TRANSFERASE A2)	2fpq	BOTULINUM NEUROTOXIN D LIGHT CHAIN (Clostridium botulinum)	4 / 7	TYR A 367 ILE A 102 GLY A 103 LEU A 110	None	0.93A	2vctD-2fpqA: undetectable	2vctD-2fpqA: 17.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZIF_B_SAMB298_0 (PUTATIVE MODIFICATION METHYLASE)	2fpq	BOTULINUM NEUROTOXIN D LIGHT CHAIN (Clostridium botulinum)	5 / 12	ALA A 36 ALA A 195 PRO A 196 GLY A 160 LEU A 157	None	1.01A	2zifB-2fpqA: undetectable	2zifB-2fpqA: 19.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3A6J_A_CRNA303_1 (CREATININE AMIDOHYDROLASE)	2fpq	BOTULINUM NEUROTOXIN D LIGHT CHAIN (Clostridium botulinum)	4 / 8	GLU A 269 HIS A 229 HIS A 233 GLU A 230	ZN A 500 (-1.8A) ZN A 500 (-3.1A) ZN A 500 (-3.3A) ZN A 500 ( 4.2A)	0.92A	3a6jA-2fpqA: undetectable	3a6jA-2fpqA: 19.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3A6J_B_CRNB304_1 (CREATININE AMIDOHYDROLASE)	2fpq	BOTULINUM NEUROTOXIN D LIGHT CHAIN (Clostridium botulinum)	4 / 7	GLU A 269 HIS A 229 HIS A 233 GLU A 230	ZN A 500 (-1.8A) ZN A 500 (-3.1A) ZN A 500 (-3.3A) ZN A 500 ( 4.2A)	0.90A	3a6jB-2fpqA: undetectable	3a6jB-2fpqA: 19.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3A6J_C_CRNC305_1 (CREATININE AMIDOHYDROLASE)	2fpq	BOTULINUM NEUROTOXIN D LIGHT CHAIN (Clostridium botulinum)	4 / 8	GLU A 269 HIS A 229 HIS A 233 GLU A 230	ZN A 500 (-1.8A) ZN A 500 (-3.1A) ZN A 500 (-3.3A) ZN A 500 ( 4.2A)	0.91A	3a6jC-2fpqA: undetectable	3a6jC-2fpqA: 19.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3A6J_E_CRNE306_1 (CREATININE AMIDOHYDROLASE)	2fpq	BOTULINUM NEUROTOXIN D LIGHT CHAIN (Clostridium botulinum)	4 / 8	GLU A 269 HIS A 229 HIS A 233 GLU A 230	ZN A 500 (-1.8A) ZN A 500 (-3.1A) ZN A 500 (-3.3A) ZN A 500 ( 4.2A)	0.93A	3a6jE-2fpqA: undetectable	3a6jE-2fpqA: 19.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3A6J_F_CRNF307_1 (CREATININE AMIDOHYDROLASE)	2fpq	BOTULINUM NEUROTOXIN D LIGHT CHAIN (Clostridium botulinum)	4 / 8	GLU A 269 HIS A 229 HIS A 233 GLU A 230	ZN A 500 (-1.8A) ZN A 500 (-3.1A) ZN A 500 (-3.3A) ZN A 500 ( 4.2A)	0.90A	3a6jF-2fpqA: undetectable	3a6jF-2fpqA: 19.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EKQ_A_ROCA100_2 (PROTEASE)	2fpq	BOTULINUM NEUROTOXIN D LIGHT CHAIN (Clostridium botulinum)	5 / 9	LEU A 192 VAL A 45 ILE A 91 ILE A 97 ILE A 158	None	0.92A	3ekqB-2fpqA: undetectable	3ekqB-2fpqA: 14.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3FPJ_B_SAMB301_0 (PUTATIVE UNCHARACTERIZED PROTEIN)	2fpq	BOTULINUM NEUROTOXIN D LIGHT CHAIN (Clostridium botulinum)	5 / 12	ILE A 158 VAL A 156 ILE A 191 ILE A 136 VAL A 194	None	1.11A	3fpjB-2fpqA: undetectable	3fpjB-2fpqA: 21.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3G9E_A_RO7A1_1 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	2fpq	BOTULINUM NEUROTOXIN D LIGHT CHAIN (Clostridium botulinum)	5 / 12	SER A 155 VAL A 5 ILE A 39 LEU A 238 TYR A 239	None	1.26A	3g9eA-2fpqA: undetectable	3g9eA-2fpqA: 20.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3IK3_B_0LIB2_2 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	2fpq	BOTULINUM NEUROTOXIN D LIGHT CHAIN (Clostridium botulinum)	4 / 7	LEU A 238 VAL A 34 ILE A 136 ARG A 49	None	1.10A	3ik3B-2fpqA: undetectable	3ik3B-2fpqA: 20.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KEC_B_HAEB271_1 (COLLAGENASE 3)	2fpq	BOTULINUM NEUROTOXIN D LIGHT CHAIN (Clostridium botulinum)	3 / 3	HIS A 229 GLU A 230 HIS A 233	ZN A 500 (-3.1A) ZN A 500 ( 4.2A) ZN A 500 (-3.3A)	0.17A	3kecB-2fpqA: undetectable	3kecB-2fpqA: 17.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3O1C_A_ADNA127_1 (HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN 1)	2fpq	BOTULINUM NEUROTOXIN D LIGHT CHAIN (Clostridium botulinum)	5 / 10	ILE A 39 PHE A 94 ILE A 90 SER A 155 LEU A 231	None	1.21A	3o1cA-2fpqA: undetectable	3o1cA-2fpqA: 14.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3UA5_A_06XA501_1 (CYTOCHROME P450 2B6)	2fpq	BOTULINUM NEUROTOXIN D LIGHT CHAIN (Clostridium botulinum)	5 / 8	ILE A 90 ILE A 97 THR A 232 LEU A 110 VAL A 156	None	1.46A	3ua5A-2fpqA: undetectable	3ua5A-2fpqA: 22.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QYN_B_RTLB201_0 (RETINOL-BINDING PROTEIN 2)	2fpq	BOTULINUM NEUROTOXIN D LIGHT CHAIN (Clostridium botulinum)	5 / 12	PHE A 94 THR A 272 LEU A 192 LEU A 106 LEU A 110	None ZN A 500 ( 4.8A) None None None	1.30A	4qynB-2fpqA: undetectable	4qynB-2fpqA: 14.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R7L_A_SHHA709_1 (LEUKOTRIENE A-4 HYDROLASE)	2fpq	BOTULINUM NEUROTOXIN D LIGHT CHAIN (Clostridium botulinum)	5 / 12	HIS A 229 GLU A 230 HIS A 233 GLU A 269 TYR A 375	ZN A 500 (-3.1A) ZN A 500 ( 4.2A) ZN A 500 (-3.3A) ZN A 500 (-1.8A) None	0.45A	4r7lA-2fpqA: 2.1	4r7lA-2fpqA: 23.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4W9N_C_CCSC1548_0 (ENOYL-[ACYL-CARRIER- PROTEIN] REDUCTASE)	2fpq	BOTULINUM NEUROTOXIN D LIGHT CHAIN (Clostridium botulinum)	3 / 3	ALA A 36 TRP A 44 VAL A 45	None	0.20A	4w9nC-2fpqA: undetectable	4w9nC-2fpqA: 21.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YJI_A_TYLA502_1 (ARYL ACYLAMIDASE)	2fpq	BOTULINUM NEUROTOXIN D LIGHT CHAIN (Clostridium botulinum)	4 / 7	LEU A 354 GLY A 240 GLY A 185 ILE A 300	None	0.73A	4yjiA-2fpqA: undetectable	4yjiA-2fpqA: 22.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5A06_F_SORF1343_0 (ALDOSE-ALDOSE OXIDOREDUCTASE)	2fpq	BOTULINUM NEUROTOXIN D LIGHT CHAIN (Clostridium botulinum)	4 / 7	ARG A 372 ASP A 167 TYR A 168 TYR A 375	None	1.22A	5a06F-2fpqA: undetectable	5a06F-2fpqA: 19.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EWU_A_BEZA1401_0 (MAGNESIUM-CHELATASE SUBUNIT CHLH, CHLOROPLASTIC)	2fpq	BOTULINUM NEUROTOXIN D LIGHT CHAIN (Clostridium botulinum)	4 / 6	GLY A 274 SER A 359 VAL A 361 HIS A 229	None None None ZN A 500 (-3.1A)	1.11A	5ewuA-2fpqA: undetectable	5ewuA-2fpqA: 20.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5FA8_A_SAMA301_1 (RIBOSOMAL PROTEIN L11 METHYLTRANSFERASE, PUTATIVE)	2fpq	BOTULINUM NEUROTOXIN D LIGHT CHAIN (Clostridium botulinum)	3 / 3	THR A 173 ASP A 167 GLU A 230	None None ZN A 500 ( 4.2A)	0.81A	5fa8A-2fpqA: undetectable	5fa8A-2fpqA: 16.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5KC4_A_RBFA201_2 (RIBOFLAVIN TRANSPORTER RIBU)	2fpq	BOTULINUM NEUROTOXIN D LIGHT CHAIN (Clostridium botulinum)	3 / 3	LYS A 104 LEU A 227 ILE A 43	None	0.79A	5kc4A-2fpqA: undetectable	5kc4A-2fpqA: 16.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5KQX_A_ROCA101_2 (PROTEASE E35D-SQV)	2fpq	BOTULINUM NEUROTOXIN D LIGHT CHAIN (Clostridium botulinum)	5 / 9	LEU A 192 VAL A 45 ILE A 91 ILE A 97 ILE A 158	None	0.99A	5kqxB-2fpqA: undetectable	5kqxB-2fpqA: 15.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5OF1_A_SALA301_1 (SPORE COAT-ASSOCIATED PROTEIN N)	2fpq	BOTULINUM NEUROTOXIN D LIGHT CHAIN (Clostridium botulinum)	4 / 5	ALA A 385 VAL A 383 PHE A 399 ILE A 415	None None None K A 501 (-4.9A)	0.83A	5of1A-2fpqA: undetectable	5of1A-2fpqA: 11.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5OF1_B_SALB301_1 (SPORE COAT-ASSOCIATED PROTEIN N)	2fpq	BOTULINUM NEUROTOXIN D LIGHT CHAIN (Clostridium botulinum)	4 / 5	ALA A 385 VAL A 383 PHE A 399 ILE A 415	None None None K A 501 (-4.9A)	0.82A	5of1B-2fpqA: undetectable	5of1B-2fpqA: 11.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5PAH_A_LDPA600_1 (PHENYLALANINE 4-MONOOXYGENASE)	2fpq	BOTULINUM NEUROTOXIN D LIGHT CHAIN (Clostridium botulinum)	4 / 4	HIS A 233 HIS A 229 TYR A 375 GLU A 269	ZN A 500 (-3.3A) ZN A 500 (-3.1A) None ZN A 500 (-1.8A)	1.27A	5pahA-2fpqA: undetectable	5pahA-2fpqA: 21.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V3D_A_FCNA205_1 (FOSFOMYCIN RESISTANCE PROTEIN)	2fpq	BOTULINUM NEUROTOXIN D LIGHT CHAIN (Clostridium botulinum)	5 / 10	HIS A 233 TYR A 168 HIS A 229 TYR A 375 GLU A 269	ZN A 500 (-3.3A) None ZN A 500 (-3.1A) None ZN A 500 (-1.8A)	1.45A	5v3dA-2fpqA: 0.0 5v3dB-2fpqA: undetectable	5v3dA-2fpqA: 16.02 5v3dB-2fpqA: 16.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V5Z_A_1YNA602_2 (LANOSTEROL 14-ALPHA DEMETHYLASE)	2fpq	BOTULINUM NEUROTOXIN D LIGHT CHAIN (Clostridium botulinum)	3 / 3	GLY A 89 THR A 201 PRO A 223	None	0.41A	5v5zA-2fpqA: 0.3	5v5zA-2fpqA: 23.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5X7P_A_ACRA1471_1 (GLYCOSIDE HYDROLASE FAMILY 31 ALPHA-GLUCOSIDASE)	2fpq	BOTULINUM NEUROTOXIN D LIGHT CHAIN (Clostridium botulinum)	5 / 12	LEU A 172 GLU A 269 HIS A 236 THR A 272 HIS A 229	ZN A 500 ( 4.6A) ZN A 500 (-1.8A) None ZN A 500 ( 4.8A) ZN A 500 (-3.1A)	1.31A	5x7pA-2fpqA: 0.0	5x7pA-2fpqA: 16.38

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1D4F_C_ADNC603_2","S-ADENOSYLHOMOCYSTEINE HYDROLASE","2fpq","BOTULINUM NEUROTOXIN D LIGHT CHAIN","Clostridium botulinum",4,"GLU A 268;THR A 272;HIS A 229;LEU A 192","None; ZN A 500 ( 4.8A); ZN A 500 (-3.1A);None","1.11A","1d4fC-2fpqA:undetectable","1d4fC-2fpqA:22.31"],["1NKI_A_PPFA5001_1","PROBABLE FOSFOMYCIN RESISTANCE PROTEIN;PROBABLE FOSFOMYCIN RESISTANCE PROTEIN","2fpq","BOTULINUM NEUROTOXIN D LIGHT CHAIN","Clostridium botulinum",5,"TYR A 168;HIS A 229;TYR A 375;GLU A 269;HIS A 233","None; ZN A 500 (-3.1A);None; ZN A 500 (-1.8A); ZN A 500 (-3.3A)","1.42A","1nkiA-2fpqA:undetectable;1nkiB-2fpqA:undetectable","1nkiA-2fpqA:15.62;1nkiB-2fpqA:15.62"],["1NKI_B_PPFB5002_1","PROBABLE FOSFOMYCIN RESISTANCE PROTEIN;PROBABLE FOSFOMYCIN RESISTANCE PROTEIN","2fpq","BOTULINUM NEUROTOXIN D LIGHT CHAIN","Clostridium botulinum",5,"HIS A 233;TYR A 168;HIS A 229;TYR A 375;GLU A 269"," ZN A 500 (-3.3A);None; ZN A 500 (-3.1A);None; ZN A 500 (-1.8A)","1.41A","1nkiA-2fpqA:undetectable;1nkiB-2fpqA:undetectable","1nkiA-2fpqA:15.62;1nkiB-2fpqA:15.62"],["1NX9_A_AICA5001_1","ALPHA-AMINO ACID ESTER HYDROLASE","2fpq","BOTULINUM NEUROTOXIN D LIGHT CHAIN","Clostridium botulinum",4,"TYR A 363;TYR A 367;GLU A 360;HIS A 236","None","1.29A","1nx9A-2fpqA:undetectable","1nx9A-2fpqA:19.85"],["1NX9_B_AICB5002_1","ALPHA-AMINO ACID ESTER HYDROLASE","2fpq","BOTULINUM NEUROTOXIN D LIGHT CHAIN","Clostridium botulinum",4,"TYR A 363;TYR A 367;GLU A 360;HIS A 236","None","1.33A","1nx9B-2fpqA:undetectable","1nx9B-2fpqA:19.85"],["1NX9_C_AICC5003_1","ALPHA-AMINO ACID ESTER HYDROLASE","2fpq","BOTULINUM NEUROTOXIN D LIGHT CHAIN","Clostridium botulinum",4,"TYR A 363;TYR A 367;GLU A 360;HIS A 236","None","1.31A","1nx9C-2fpqA:undetectable","1nx9C-2fpqA:19.85"],["1NX9_D_AICD5004_1","ALPHA-AMINO ACID ESTER HYDROLASE","2fpq","BOTULINUM NEUROTOXIN D LIGHT CHAIN","Clostridium botulinum",4,"TYR A 363;TYR A 367;GLU A 360;HIS A 236","None","1.31A","1nx9D-2fpqA:undetectable","1nx9D-2fpqA:19.85"],["1SDT_B_MK1B902_1","PROTEASE RETROPEPSIN;PROTEASE RETROPEPSIN","2fpq","BOTULINUM NEUROTOXIN D LIGHT CHAIN","Clostridium botulinum",5,"LEU A 192;ILE A  91;ILE A  97;VAL A 156;ILE A 158","None","0.94A","1sdtA-2fpqA:undetectable","1sdtA-2fpqA:15.71"],["1V7Z_A_CRNA401_1","CREATININE AMIDOHYDROLASE","2fpq","BOTULINUM NEUROTOXIN D LIGHT CHAIN","Clostridium botulinum",4,"GLU A 269;HIS A 229;HIS A 233;GLU A 230"," ZN A 500 (-1.8A); ZN A 500 (-3.1A); ZN A 500 (-3.3A); ZN A 500 ( 4.2A)","0.91A","1v7zA-2fpqA:undetectable","1v7zA-2fpqA:19.24"],["1V7Z_B_CRNB3401_1","CREATININE AMIDOHYDROLASE","2fpq","BOTULINUM NEUROTOXIN D LIGHT CHAIN","Clostridium botulinum",4,"GLU A 269;HIS A 229;HIS A 233;GLU A 230"," ZN A 500 (-1.8A); ZN A 500 (-3.1A); ZN A 500 (-3.3A); ZN A 500 ( 4.2A)","0.90A","1v7zB-2fpqA:undetectable","1v7zB-2fpqA:19.24"],["1V7Z_C_CRNC4401_1","CREATININE AMIDOHYDROLASE","2fpq","BOTULINUM NEUROTOXIN D LIGHT CHAIN","Clostridium botulinum",4,"GLU A 269;HIS A 229;HIS A 233;GLU A 230"," ZN A 500 (-1.8A); ZN A 500 (-3.1A); ZN A 500 (-3.3A); ZN A 500 ( 4.2A)","0.91A","1v7zC-2fpqA:undetectable","1v7zC-2fpqA:19.24"],["1V7Z_D_CRND5401_1","CREATININE AMIDOHYDROLASE","2fpq","BOTULINUM NEUROTOXIN D LIGHT CHAIN","Clostridium botulinum",4,"GLU A 269;HIS A 229;HIS A 233;GLU A 230"," ZN A 500 (-1.8A); ZN A 500 (-3.1A); ZN A 500 (-3.3A); ZN A 500 ( 4.2A)","0.93A","1v7zD-2fpqA:undetectable","1v7zD-2fpqA:19.24"],["1V7Z_E_CRNE6401_1","CREATININE AMIDOHYDROLASE","2fpq","BOTULINUM NEUROTOXIN D LIGHT CHAIN","Clostridium botulinum",4,"GLU A 269;HIS A 229;HIS A 233;GLU A 230"," ZN A 500 (-1.8A); ZN A 500 (-3.1A); ZN A 500 (-3.3A); ZN A 500 ( 4.2A)","0.92A","1v7zE-2fpqA:undetectable","1v7zE-2fpqA:19.24"],["1V7Z_F_CRNF7401_1","CREATININE AMIDOHYDROLASE","2fpq","BOTULINUM NEUROTOXIN D LIGHT CHAIN","Clostridium botulinum",4,"GLU A 269;HIS A 229;HIS A 233;GLU A 230"," ZN A 500 (-1.8A); ZN A 500 (-3.1A); ZN A 500 (-3.3A); ZN A 500 ( 4.2A)","0.92A","1v7zF-2fpqA:undetectable","1v7zF-2fpqA:19.24"],["1WU8_C_ADNC502_1","HYPOTHETICAL PROTEIN PH0463;HYPOTHETICAL PROTEIN PH0463","2fpq","BOTULINUM NEUROTOXIN D LIGHT CHAIN","Clostridium botulinum",4,"PHE A 399;ASN A 400;ASN A 371;VAL A 224","None","1.17A","1wu8A-2fpqA:undetectable;1wu8C-2fpqA:undetectable","1wu8A-2fpqA:22.43;1wu8C-2fpqA:22.43"],["2O4P_A_TPVA300_2","PROTEASE;PROTEASE","2fpq","BOTULINUM NEUROTOXIN D LIGHT CHAIN","Clostridium botulinum",5,"LEU A 192;VAL A  45;ILE A  97;VAL A 156;ILE A 158","None","0.77A","2o4pB-2fpqA:undetectable","2o4pB-2fpqA:15.45"],["2PRG_A_BRLA1_2","PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA","2fpq","BOTULINUM NEUROTOXIN D LIGHT CHAIN","Clostridium botulinum",3,"ILE A 191;ILE A 136;LEU A 227","None","0.54A","2prgA-2fpqA:undetectable","2prgA-2fpqA:20.81"],["2R5P_B_MK1B902_1","PROTEASE;PROTEASE","2fpq","BOTULINUM NEUROTOXIN D LIGHT CHAIN","Clostridium botulinum",5,"LEU A 192;VAL A  45;ILE A  97;VAL A 156;ILE A 158","None","0.91A","2r5pA-2fpqA:undetectable","2r5pA-2fpqA:14.66"],["2R5P_D_MK1D902_1","PROTEASE;PROTEASE","2fpq","BOTULINUM NEUROTOXIN D LIGHT CHAIN","Clostridium botulinum",5,"LEU A 192;VAL A  45;ILE A  97;VAL A 156;ILE A 158","None","0.91A","2r5pC-2fpqA:undetectable","2r5pC-2fpqA:14.66"],["2VCT_C_ASDC1223_1","GLUTATHIONE S-TRANSFERASE A2","2fpq","BOTULINUM NEUROTOXIN D LIGHT CHAIN","Clostridium botulinum",4,"TYR A 367;ILE A 102;GLY A 103;LEU A 110","None","0.92A","2vctC-2fpqA:undetectable","2vctC-2fpqA:17.85"],["2VCT_D_ASDD1223_1","GLUTATHIONE S-TRANSFERASE A2","2fpq","BOTULINUM NEUROTOXIN D LIGHT CHAIN","Clostridium botulinum",4,"TYR A 367;ILE A 102;GLY A 103;LEU A 110","None","0.93A","2vctD-2fpqA:undetectable","2vctD-2fpqA:17.85"],["2ZIF_B_SAMB298_0","PUTATIVE MODIFICATION METHYLASE","2fpq","BOTULINUM NEUROTOXIN D LIGHT CHAIN","Clostridium botulinum",5,"ALA A  36;ALA A 195;PRO A 196;GLY A 160;LEU A 157","None","1.01A","2zifB-2fpqA:undetectable","2zifB-2fpqA:19.59"],["3A6J_A_CRNA303_1","CREATININE AMIDOHYDROLASE","2fpq","BOTULINUM NEUROTOXIN D LIGHT CHAIN","Clostridium botulinum",4,"GLU A 269;HIS A 229;HIS A 233;GLU A 230"," ZN A 500 (-1.8A); ZN A 500 (-3.1A); ZN A 500 (-3.3A); ZN A 500 ( 4.2A)","0.92A","3a6jA-2fpqA:undetectable","3a6jA-2fpqA:19.46"],["3A6J_B_CRNB304_1","CREATININE AMIDOHYDROLASE","2fpq","BOTULINUM NEUROTOXIN D LIGHT CHAIN","Clostridium botulinum",4,"GLU A 269;HIS A 229;HIS A 233;GLU A 230"," ZN A 500 (-1.8A); ZN A 500 (-3.1A); ZN A 500 (-3.3A); ZN A 500 ( 4.2A)","0.90A","3a6jB-2fpqA:undetectable","3a6jB-2fpqA:19.46"],["3A6J_C_CRNC305_1","CREATININE AMIDOHYDROLASE","2fpq","BOTULINUM NEUROTOXIN D LIGHT CHAIN","Clostridium botulinum",4,"GLU A 269;HIS A 229;HIS A 233;GLU A 230"," ZN A 500 (-1.8A); ZN A 500 (-3.1A); ZN A 500 (-3.3A); ZN A 500 ( 4.2A)","0.91A","3a6jC-2fpqA:undetectable","3a6jC-2fpqA:19.46"],["3A6J_E_CRNE306_1","CREATININE AMIDOHYDROLASE","2fpq","BOTULINUM NEUROTOXIN D LIGHT CHAIN","Clostridium botulinum",4,"GLU A 269;HIS A 229;HIS A 233;GLU A 230"," ZN A 500 (-1.8A); ZN A 500 (-3.1A); ZN A 500 (-3.3A); ZN A 500 ( 4.2A)","0.93A","3a6jE-2fpqA:undetectable","3a6jE-2fpqA:19.46"],["3A6J_F_CRNF307_1","CREATININE AMIDOHYDROLASE","2fpq","BOTULINUM NEUROTOXIN D LIGHT CHAIN","Clostridium botulinum",4,"GLU A 269;HIS A 229;HIS A 233;GLU A 230"," ZN A 500 (-1.8A); ZN A 500 (-3.1A); ZN A 500 (-3.3A); ZN A 500 ( 4.2A)","0.90A","3a6jF-2fpqA:undetectable","3a6jF-2fpqA:19.46"],["3EKQ_A_ROCA100_2","PROTEASE;PROTEASE","2fpq","BOTULINUM NEUROTOXIN D LIGHT CHAIN","Clostridium botulinum",5,"LEU A 192;VAL A  45;ILE A  91;ILE A  97;ILE A 158","None","0.92A","3ekqB-2fpqA:undetectable","3ekqB-2fpqA:14.66"],["3FPJ_B_SAMB301_0","PUTATIVE UNCHARACTERIZED PROTEIN","2fpq","BOTULINUM NEUROTOXIN D LIGHT CHAIN","Clostridium botulinum",5,"ILE A 158;VAL A 156;ILE A 191;ILE A 136;VAL A 194","None","1.11A","3fpjB-2fpqA:undetectable","3fpjB-2fpqA:21.11"],["3G9E_A_RO7A1_1","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA","2fpq","BOTULINUM NEUROTOXIN D LIGHT CHAIN","Clostridium botulinum",5,"SER A 155;VAL A   5;ILE A  39;LEU A 238;TYR A 239","None","1.26A","3g9eA-2fpqA:undetectable","3g9eA-2fpqA:20.81"],["3IK3_B_0LIB2_2","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","2fpq","BOTULINUM NEUROTOXIN D LIGHT CHAIN","Clostridium botulinum",4,"LEU A 238;VAL A  34;ILE A 136;ARG A  49","None","1.10A","3ik3B-2fpqA:undetectable","3ik3B-2fpqA:20.54"],["3KEC_B_HAEB271_1","COLLAGENASE 3","2fpq","BOTULINUM NEUROTOXIN D LIGHT CHAIN","Clostridium botulinum",3,"HIS A 229;GLU A 230;HIS A 233"," ZN A 500 (-3.1A); ZN A 500 ( 4.2A); ZN A 500 (-3.3A)","0.17A","3kecB-2fpqA:undetectable","3kecB-2fpqA:17.63"],["3O1C_A_ADNA127_1","HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN 1","2fpq","BOTULINUM NEUROTOXIN D LIGHT CHAIN","Clostridium botulinum",5,"ILE A  39;PHE A  94;ILE A  90;SER A 155;LEU A 231","None","1.21A","3o1cA-2fpqA:undetectable","3o1cA-2fpqA:14.77"],["3UA5_A_06XA501_1","CYTOCHROME P450 2B6","2fpq","BOTULINUM NEUROTOXIN D LIGHT CHAIN","Clostridium botulinum",5,"ILE A  90;ILE A  97;THR A 232;LEU A 110;VAL A 156","None","1.46A","3ua5A-2fpqA:undetectable","3ua5A-2fpqA:22.31"],["4QYN_B_RTLB201_0","RETINOL-BINDING PROTEIN 2","2fpq","BOTULINUM NEUROTOXIN D LIGHT CHAIN","Clostridium botulinum",5,"PHE A  94;THR A 272;LEU A 192;LEU A 106;LEU A 110","None; ZN A 500 ( 4.8A);None;None;None","1.30A","4qynB-2fpqA:undetectable","4qynB-2fpqA:14.77"],["4R7L_A_SHHA709_1","LEUKOTRIENE A-4 HYDROLASE","2fpq","BOTULINUM NEUROTOXIN D LIGHT CHAIN","Clostridium botulinum",5,"HIS A 229;GLU A 230;HIS A 233;GLU A 269;TYR A 375"," ZN A 500 (-3.1A); ZN A 500 ( 4.2A); ZN A 500 (-3.3A); ZN A 500 (-1.8A);None","0.45A","4r7lA-2fpqA:2.1","4r7lA-2fpqA:23.44"],["4W9N_C_CCSC1548_0","ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE","2fpq","BOTULINUM NEUROTOXIN D LIGHT CHAIN","Clostridium botulinum",3,"ALA A  36;TRP A  44;VAL A  45","None","0.20A","4w9nC-2fpqA:undetectable","4w9nC-2fpqA:21.98"],["4YJI_A_TYLA502_1","ARYL ACYLAMIDASE","2fpq","BOTULINUM NEUROTOXIN D LIGHT CHAIN","Clostridium botulinum",4,"LEU A 354;GLY A 240;GLY A 185;ILE A 300","None","0.73A","4yjiA-2fpqA:undetectable","4yjiA-2fpqA:22.45"],["5A06_F_SORF1343_0","ALDOSE-ALDOSE OXIDOREDUCTASE","2fpq","BOTULINUM NEUROTOXIN D LIGHT CHAIN","Clostridium botulinum",4,"ARG A 372;ASP A 167;TYR A 168;TYR A 375","None","1.22A","5a06F-2fpqA:undetectable","5a06F-2fpqA:19.47"],["5EWU_A_BEZA1401_0","MAGNESIUM-CHELATASE SUBUNIT CHLH, CHLOROPLASTIC","2fpq","BOTULINUM NEUROTOXIN D LIGHT CHAIN","Clostridium botulinum",4,"GLY A 274;SER A 359;VAL A 361;HIS A 229","None;None;None; ZN A 500 (-3.1A)","1.11A","5ewuA-2fpqA:undetectable","5ewuA-2fpqA:20.17"],["5FA8_A_SAMA301_1","RIBOSOMAL PROTEIN L11 METHYLTRANSFERASE, PUTATIVE","2fpq","BOTULINUM NEUROTOXIN D LIGHT CHAIN","Clostridium botulinum",3,"THR A 173;ASP A 167;GLU A 230","None;None; ZN A 500 ( 4.2A)","0.81A","5fa8A-2fpqA:undetectable","5fa8A-2fpqA:16.70"],["5KC4_A_RBFA201_2","RIBOFLAVIN TRANSPORTER RIBU","2fpq","BOTULINUM NEUROTOXIN D LIGHT CHAIN","Clostridium botulinum",3,"LYS A 104;LEU A 227;ILE A  43","None","0.79A","5kc4A-2fpqA:undetectable","5kc4A-2fpqA:16.59"],["5KQX_A_ROCA101_2","PROTEASE E35D-SQV;PROTEASE E35D-SQV","2fpq","BOTULINUM NEUROTOXIN D LIGHT CHAIN","Clostridium botulinum",5,"LEU A 192;VAL A  45;ILE A  91;ILE A  97;ILE A 158","None","0.99A","5kqxB-2fpqA:undetectable","5kqxB-2fpqA:15.71"],["5OF1_A_SALA301_1","SPORE COAT-ASSOCIATED PROTEIN N","2fpq","BOTULINUM NEUROTOXIN D LIGHT CHAIN","Clostridium botulinum",4,"ALA A 385;VAL A 383;PHE A 399;ILE A 415","None;None;None;  K A 501 (-4.9A)","0.83A","5of1A-2fpqA:undetectable","5of1A-2fpqA:11.03"],["5OF1_B_SALB301_1","SPORE COAT-ASSOCIATED PROTEIN N","2fpq","BOTULINUM NEUROTOXIN D LIGHT CHAIN","Clostridium botulinum",4,"ALA A 385;VAL A 383;PHE A 399;ILE A 415","None;None;None;  K A 501 (-4.9A)","0.82A","5of1B-2fpqA:undetectable","5of1B-2fpqA:11.03"],["5PAH_A_LDPA600_1","PHENYLALANINE 4-MONOOXYGENASE","2fpq","BOTULINUM NEUROTOXIN D LIGHT CHAIN","Clostridium botulinum",4,"HIS A 233;HIS A 229;TYR A 375;GLU A 269"," ZN A 500 (-3.3A); ZN A 500 (-3.1A);None; ZN A 500 (-1.8A)","1.27A","5pahA-2fpqA:undetectable","5pahA-2fpqA:21.33"],["5V3D_A_FCNA205_1","FOSFOMYCIN RESISTANCE PROTEIN;FOSFOMYCIN RESISTANCE PROTEIN","2fpq","BOTULINUM NEUROTOXIN D LIGHT CHAIN","Clostridium botulinum",5,"HIS A 233;TYR A 168;HIS A 229;TYR A 375;GLU A 269"," ZN A 500 (-3.3A);None; ZN A 500 (-3.1A);None; ZN A 500 (-1.8A)","1.45A","5v3dA-2fpqA:0.0;5v3dB-2fpqA:undetectable","5v3dA-2fpqA:16.02;5v3dB-2fpqA:16.02"],["5V5Z_A_1YNA602_2","LANOSTEROL 14-ALPHA DEMETHYLASE","2fpq","BOTULINUM NEUROTOXIN D LIGHT CHAIN","Clostridium botulinum",3,"GLY A  89;THR A 201;PRO A 223","None","0.41A","5v5zA-2fpqA:0.3","5v5zA-2fpqA:23.93"],["5X7P_A_ACRA1471_1","GLYCOSIDE HYDROLASE FAMILY 31 ALPHA-GLUCOSIDASE","2fpq","BOTULINUM NEUROTOXIN D LIGHT CHAIN","Clostridium botulinum",5,"LEU A 172;GLU A 269;HIS A 236;THR A 272;HIS A 229"," ZN A 500 ( 4.6A); ZN A 500 (-1.8A);None; ZN A 500 ( 4.8A); ZN A 500 (-3.1A)","1.31A","5x7pA-2fpqA:0.0","5x7pA-2fpqA:16.38"]]